Cellebrite shares rise 1.77% premarket after appointing Thomas E. Hogan as CEO and reporting Q2 revenue beat.
ByAinvest
Friday, Aug 15, 2025 5:58 am ET1min read
CLBT--
Cellebrite Di Ltd. rose 1.77% in premarket trading, with the company reporting that Thomas E. Hogan has been appointed as the new CEO, effective August 14, 2025. Hogan, who has a proven track record of generating exceptional shareholder returns, had previously served as the company's interim CEO and executive chairman. Additionally, the company's Q2 revenue beat estimates, contributing to the positive market sentiment.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet